Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity

Acta Pharmacologica Sinica

Volumn 31, Issue 12, 2010, Pages 1611-1617

  Liu, Der Zen ^a   Hu, Chieh Min ^b   Huang, Chung Hsiung ^b   Wey, Shiaw Pyng ^c   Jan, Tong Rong ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

cannabidiol; cytokine; delayed type hypersensitivity; inteferon ; interleukin 10; interleukin 4; macrophage; T cell; tumor necrosis factor

Indexed keywords

CANNABIDIOL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT PAD; HISTOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SPLEEN CELL; SWELLING; T LYMPHOCYTE;

ANIMALS; CANNABIDIOL; HYPERSENSITIVITY, DELAYED; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649937735     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.155     Document Type: Article

References (29)

1. Mechoulam R. Marihuana chemistry. Science 1970;168:1159-66.
2. Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO. Cannabidiol-recent advances. Chem Biodivers 2007;4:1678-92.
3. Turner CE, Elsohly MA, Boeren EG. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 1980;43:169-234.
4. Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Maiello F, et al. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med 2009;87:1111-21.
5. Burstein SH, Zurier RB. Cannabinoids, endocannabinoids, and related analogs in infammation. AAPS J 2009;11:109-19.
6. Jan TR, Su ST, Wu HY, Liao MH. Suppressive effects of cannabidiol on antigen-specifc antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice. Int Immuno pharmacol 2007;7:773-80.
7. Kaplan BL, Springs AE, Kaminski NE. The profle of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Biochem Pharmacol 2008;76:726-37.
8. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003;74:486-96.
9. Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005;5:400-11.
10. Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 2006;39:143-51.
11. Lee CY, Wey SP, Liao MH, Hsu WL, Wu HY, Jan TR. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. Int Immunopharmacol 2008;8:732-40.
12. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collageninduced arthritis. Proc Natl Acad Sci USA 2000;97:9561-6.
13. McCoy KL, Gainey D, Cabral GA. Delta-9-tetrahydrocannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther 1995;273:1216-23.
14. Wu HY, Chu RM, Wang CC, Lee CY, Lin SH, Jan TR. Cannabidiolinduced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8. Toxicol Appl Pharmacol 2008;226:260-70.
15. Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD. Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol 2002;133:124-31.
16. Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R, et al. Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology 2008;54:244-9.
17. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
18. Flavell RA. The molecular basis of T cell differentiation. Immunol Res 1999;19:159-68.
19. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8:223-46.
20. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
21. Crow MK, Kirou KA. Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:541-7.
22. Gordon JN, Di Sabatino A, Macdonald TT. The pathophysiologic rationale for biological therapies in infammatory bowel disease. Curr Opin Gastroenterol 2005;21:431-7.
23. Wu C, Yang G, Bermudez-Humaran LG, Pang Q, Zeng Y, Wang J, et al. Immuno modulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Int Immunopharmacol 2006;6:610-5.
24. Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, et al. The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J Neuroimmunol 2005;159:97-105.
25. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987;138:3688-94.
26. Kobayashi K, Kaneda K, Kasama T. Immunopathogenesis of delayedtype hypersensitivity. Microsc Res Tech 2001;53:241-5.
27. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 2001;134:845-52.
28. Correa F, Hernangómez M, Mestre L, Loría F, Spagnolo A, Docagne F, et al. Anandamide enhances IL-10 production in activated microglia by targeting CB (2) receptors: roles of ERK1/2, JNK, and NF-kappaB. Glia 2010;58:135-47.
29. Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, et al. The endocannabinoid anandamide protects neurons during CNS infammation by induction of MKP-1 in microglial cells. Neuron 2006;49:67-79.